Medicare Enrolled
Matthew Holcomb, NP-C
Nurse Practitioner - Family · Amarillo, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Holcomb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Holcomb?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Holcomb
Matthew Holcomb is a nurse practitioner - family in Amarillo, TX, with 15 years of NPI registration. Based on federal Medicare data, Holcomb performed 20,497 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Holcomb received a total of $3,194 from 26 pharmaceutical and/or device companies across 158 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Holcomb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 1% volume in TX
$3,194 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗20,497
Medicare services
Top 1% in TX for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
7,990 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 5,340 | $18 | $45 |
| BCG treatment for bladder cancer | 2,250 | $2 | $7 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,217 | $3 | $21 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
970 | $51 | $175 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
458 | $8 | $50 |
| PSA test (prostate cancer screening) | 451 | $18 | $70 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
223 | $38 | $250 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 204 | $133 | $1,000 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
201 | $31 | $103 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
131 | $8 | $50 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
130 | $18 | $70 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
118 | $25 | $88 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
104 | $83 | $259 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
88 | $61 | $259 |
| Sex hormone binding globulin level test A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream. |
77 | $21 | $75 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
59 | $18 | $66 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
53 | $58 | $275 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
48 | $2 | $8 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
48 | $2 | $8 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
48 | $14 | $48 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
45 | $65 | $276 |
| Simple change of bladder tube | 39 | $59 | $275 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
35 | $20 | $75 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
31 | $5 | $20 |
| Catheter specimen collection A procedure to collect a specimen using a catheter. This service is available in all places of service. |
29 | $8 | $10 |
| Total estradiol level test A blood test that measures the total amount of estradiol, a form of estrogen, in the body. |
28 | $27 | $86 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
22 | $83 | $375 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $99 | $397 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
16 | $74 | $402 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
15 | $57 | $257 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
12 | $48 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.1% high complexity
68.6% medium
31.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,194
Total received (2021-2024)
Avg $799/year across 4 years
Top 9% in TX for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
158
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$641
2023
$689
2022
$1,164
2021
$700
Payments by company (2024)
Janssen Biotech, Inc.
$183
Sumitomo Pharma America, Inc.
$86
Merck Sharp & Dohme LLC
$80
PFIZER INC.
$80
Dendreon Pharmaceuticals LLC
$62
Astellas Pharma US Inc
$35
Novartis Pharmaceuticals Corporation
$30
UROGEN PHARMA, INC.
$30
Teleflex LLC
$20
Blue Earth Diagnostics Limited
$17
180 Medical, Inc.
$16
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2021-2024) ›
Astellas Pharma US Inc
$558
Dendreon Pharmaceuticals LLC
$473
Janssen Biotech, Inc.
$380
ABBVIE INC.
$250
Myriad Genetic Laboratories, Inc.
$218
Merck Sharp & Dohme LLC
$186
UroGen Pharma, Inc.
$154
PFIZER INC.
$132
AbbVie Inc.
$108
Sumitomo Pharma America, Inc.
$103
UROVANT SCIENCES INC
$101
Amgen Inc.
$93
Blue Earth Diagnostics Limited
$64
TOLMAR Pharmaceuticals, Inc.
$63
Bayer HealthCare Pharmaceuticals Inc.
$44
Antares Pharma, Inc.
$41
180 Medical, Inc.
$35
Teleflex LLC
$35
Novartis Pharmaceuticals Corporation
$30
UROGEN PHARMA, INC.
$30
Sun Pharmaceutical Industries Inc.
$19
Coloplast Corp
$19
Laborie Medical Technologies Corp.
$16
Alnylam Pharmaceuticals Inc.
$16
Tolmar, Inc.
$14
Myovant Sciences Inc.
$12
Top 3 companies account for 44.2% of all-time payments
Associated products mentioned in payments ›
Axumin · BRAC CDx · ELIGARD · ERLEADA · GEMTESA · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · OXLUMO · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · Prolaris · SpeediCath · UROLIFT · UroLift System · XGEVA · XTANDI · XYOSTED · Xtandi · YONSA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family nurse practitioners in nearby ZIP areas
279
County median income
$50,448
Nearest hospital to ZIP centroid (approximate)
NORTHWEST TEXAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Holcomb is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Holcomb experienced with testosterone injection?
Based on Medicare claims data, Holcomb performed 7,990 testosterone injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Holcomb receive payments from pharmaceutical companies?
Yes. Holcomb received a total of $3,194 from 26 companies across 158 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Holcomb's costs compare to other family nurse practitioners in Amarillo?
Holcomb's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Holcomb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Amarillo
Browse family nurse practitioners in Amarillo ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in TX
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in TX
Which TX family nurse practitioners receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology